Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hypertension

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 55 articles: HTML format

Single Articles

May 2008
1. FERGUSON JM , Minas J, Siapantas S, Komesaroff PA, et al
   Effects of a Fixed-dose ACE Inhibitor-Diuretic Combination on Ambulatory Blood Pressure and Arterial Properties in Isolated Systolic Hypertension.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. MANCUSO P , Rahman A, Hershey SD, Dandu L, et al
   1,25-Dihydroxyvitamin-D3 Treatment Reduces Cardiac Hypertrophy and Left Ventricular Diameter in Spontaneously Hypertensive Heart Failure-Prone (cp/+) Rats Independent of Changes in Serum Leptin.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. DI VERNIERO CA , Silberman EA, Mayer MA, Opezzo JA, et al
   In Vitro and In Vivo Pharmacodynamic Properties of Metoprolol in Fructose-Fed Hypertensive Rats.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. RODRIGUES SF , Dossantos RA, de Oliveira MA, Rastelli VM, et al
   Amlodipine Reduces the Antimigratory Effect of Diclofenac in Spontaneously Hypertensive Rats.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. LIANG B , Leenen FH
   Prevention of Salt-Induced Hypertension and Fibrosis by AT1-Receptor Blockers in Dahl S Rats.
   J Cardiovasc Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. SABINO B , Lessa MA, Nascimento AR, Rodrigues CA, et al
   Effects of Antihypertensive Drugs on Capillary Rarefaction in Spontaneously Hypertensive Rats: Intravital Microscopy and Histologic Analysis.
   J Cardiovasc Pharmacol. 2008;51:402-409.
   PubMed     Related articles    Abstract available
   
   
   March 2008
7. FUKUI S , Fukumoto Y, Suzuki J, Saji K, et al
   Long-term Inhibition of Rho-kinase Ameliorates Diastolic Heart Failure in Hypertensive Rats.
   J Cardiovasc Pharmacol. 2008;51:317-326.
   PubMed     Related articles    Abstract available
   
   
   
8. CHAN SL , Tabellion A, Bagrel D, Perrin-Sarrado C, et al
   Impact of Chronic Treatment With Red Wine Polyphenols (RWP) on Cerebral Arterioles in the Spontaneous Hypertensive Rat.
   J Cardiovasc Pharmacol. 2008;51:304-310.
   PubMed     Related articles    Abstract available
   
   
   
9. ISSIAKHEM M , Liu KL, Benzoni D
   Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments.
   J Cardiovasc Pharmacol. 2008;51:280-5.
   PubMed     Related articles    Abstract available
   
   
   
10. MACKRAJ I , Govender T, Ramesar S
    The Antihypertensive Effects of Quercetin in a Salt-sensitive Model of Hypertension.
    J Cardiovasc Pharmacol. 2008;51:239-245.
    PubMed     Related articles    Abstract available
    
    
    
11. FOGARI R , Zoppi A, Mugellini A, Corradi L, et al
    Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes Mellitus.
    J Cardiovasc Pharmacol. 2008;51:217-222.
    PubMed     Related articles    Abstract available
    
    
    February 2008
12. MASOLI O , Redruello M, Balino NP, Grynberg L, et al
    Use of Nebivolol For the Treatment of Endothelial Dysfunction in Patients With Hypertension: The EDEN Registry.
    J Cardiovasc Pharmacol. 2008;51:202-7.
    PubMed     Related articles    Abstract available
    
    
    January 2008
13. XU Z , Okamoto H, Akino M, Onozuka H, et al
    Pravastatin Attenuates Left Ventricular Remodeling and Diastolic Dysfunction in Angiotensin II-Induced Hypertensive Mice.
    J Cardiovasc Pharmacol. 2008;51:62-70.
    PubMed     Related articles    Abstract available
    
    
    
14. KATO T , Nasu T, Sonoda H, Ito KM, et al
    Evaluation of Olmesartan Medoxomil in the Rat Monocrotaline Model of Pulmonary Hypertension.
    J Cardiovasc Pharmacol. 2008;51:18-23.
    PubMed     Related articles    Abstract available
    
    
    
15. GARCIA JA , Dos Santos L, Moura AL, Ricardo KF, et al
    S-Nitroso-N-Acetylcysteine (SNAC) Prevents Myocardial Alterations in Hypercholesterolemic LDL Receptor Knockout Mice by Antiinflammatory Action.
    J Cardiovasc Pharmacol. 2008;51:78-85.
    PubMed     Related articles    Abstract available
    
    
    December 2007
16. HOMMA N , Nagaoka T, Morio Y, Ota H, et al
    Endothelin-1 and Serotonin are Involved in Activation of RhoA/Rho Kinase Signaling in the Chronically Hypoxic Hypertensive Rat Pulmonary Circulation.
    J Cardiovasc Pharmacol. 2007;50:697-702.
    PubMed     Related articles    Abstract available
    
    
    
17. KAGOTA S , Tada Y, Kubota Y, Nejime N, et al
    Peroxynitrite is Involved in the Dysfunction of Vasorelaxation in SHR/NDmcr-cp Rats, Spontaneously Hypertensive Obese Rats.
    J Cardiovasc Pharmacol. 2007;50:677-685.
    PubMed     Related articles    Abstract available
    
    
    
18. QIN XP , Zeng SY, Li D, Chen QQ, et al
    Calcitonin Gene-Related Peptide-Mediated Depressor Effect and Inhibiting Vascular Hypertrophy of Rutaecarpine in Renovascular Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;50:654-659.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. COLLE SD , Morello F, Rabbia F, Milan A, et al
    Antihypertensive drugs and the sympathetic nervous system.
    J Cardiovasc Pharmacol. 2007;50:487-96.
    PubMed     Related articles    Abstract available
    
    
    
20. FUNK CD , Fitzgerald GA
    COX-2 Inhibitors and Cardiovascular Risk.
    J Cardiovasc Pharmacol. 2007;50:470-479.
    PubMed     Related articles    Abstract available
    
    
    October 2007
21. NIGRIS FD , Balestrieri ML, Williams-Ignarro S, D'armiento FP, et al
    Therapeutic Effects of Autologous Bone Marrow Cells and Metabolic Intervention in the Ischemic Hindlimb of Spontaneously Hypertensive Rats Involve Reduced Cell Senescence and CXCR4/Akt/eNOS Pathways.
    J Cardiovasc Pharmacol. 2007;50:424-433.
    PubMed     Related articles    Abstract available
    
    
    
22. BENNDORF RA , Appel D, Maas R, Schwedhelm E, et al
    Telmisartan Improves Endothelial Function in Patients With Essential Hypertension.
    J Cardiovasc Pharmacol. 2007;50:367-371.
    PubMed     Related articles    Abstract available
    
    
    September 2007
23. RUGALE C , Delbosc S, Mimran A, Jover B, et al
    Simvastatin Reverses Target Organ Damage and Oxidative Stress in Angiotensin II Hypertension: Comparison With Apocynin, Tempol, and Hydralazine.
    J Cardiovasc Pharmacol. 2007;50:293-8.
    PubMed     Related articles    Abstract available
    
    
    
24. CHIAMVIMONVAT N , Ho CM, Tsai HJ, Hammock BD, et al
    The Soluble Epoxide Hydrolase as a Pharmaceutical Target for Hypertension.
    J Cardiovasc Pharmacol. 2007;50:225-237.
    PubMed     Related articles    Abstract available
    
    
    
25. DAULL P , Jeng AY, Battistini B
    Towards Triple Vasopeptidase Inhibitors for the Treatment of Cardiovascular Diseases.
    J Cardiovasc Pharmacol. 2007;50:247-256.
    PubMed     Related articles    Abstract available
    
    
    August 2007
26. TAWARA S , Fukumoto Y, Shimokawa H
    Effects of Combined Therapy With a Rho-Kinase Inhibitor and Prostacyclin on Monocrotaline-Induced Pulmonary Hypertension in Rats.
    J Cardiovasc Pharmacol. 2007;50:195-200.
    PubMed     Related articles    Abstract available
    
    
    
27. ISHIMARU K , Ueno H, Kagitani S, Takabayashi D, et al
    Fasudil Attenuates Myocardial Fibrosis in Association With Inhibition of Monocyte/Macrophage Infiltration in the Heart of DOCA/Salt Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;50:187-94.
    PubMed     Related articles    Abstract available
    
    
    
28. KIM BH , Sandock KD, Robertson TP, Lewis SJ, et al
    Dietary Effects of Structured Lipids and Phytosteryl Esters on Cardiovascular Function in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;50:176-186.
    PubMed     Related articles    Abstract available
    
    
    
29. LEIBOVITZ E , Schiffrin EL
    PPAR Activation: A New Target for the Treatment of Hypertension.
    J Cardiovasc Pharmacol. 2007;50:120-5.
    PubMed     Related articles    Abstract available
    
    
    
30. DANSER AH
    Novel drugs targeting hypertension: Renin inhibitors.
    J Cardiovasc Pharmacol. 2007;50:105-11.
    PubMed     Related articles    Abstract available
    
    
    July 2007
31. TINEL H
    Beneficial effects of the combination of nifedipine and losartan in hypertensive dahl salt-sensitive rats.
    J Cardiovasc Pharmacol. 2007;50:75-82.
    PubMed     Related articles    Abstract available
    
    
    
32. DE GROOT AA , Mathy MJ, van Zwieten PA, Peters SL, et al
    Vasodilator effects of nebivolol in a rat model of hypertension and a rabbit model of congestive heart failure.
    J Cardiovasc Pharmacol. 2007;50:56-60.
    PubMed     Related articles    Abstract available
    
    
    
33. LIU L , Zhao SP, Zhou HN, Li QZ, et al
    Effect of Fluvastatin and Valsartan, Alone and in Combination, on Postprandial Vascular Inflammation and Fibrinolytic Activity in Patients With Essential Hypertension.
    J Cardiovasc Pharmacol. 2007;50:50-55.
    PubMed     Related articles    Abstract available
    
    
    
34. WILLIAMS HC , Griendling KK
    NADPH oxidase inhibitors: new antihypertensive agents?
    J Cardiovasc Pharmacol. 2007;50:9-16.
    PubMed     Related articles    Abstract available
    
    
    
35. LEIBOVITZ E , Schiffrin EL
    Novel drugs targeting hypertension: Renin inhibitors and beyond.
    J Cardiovasc Pharmacol. 2007;50:3-8.
    PubMed     Related articles    Abstract available
    
    
    
36. BOOZ GW
    Devising new drugs for the treatment of hypertension - "novel drugs targeting hypertension: Renin inhibitors and beyond".
    J Cardiovasc Pharmacol. 2007;50:1-2.
    PubMed     Related articles   
    
    
    
37. LIAO JK , Seto M, Noma K
    Rho kinase (ROCK) inhibitors.
    J Cardiovasc Pharmacol. 2007;50:17-24.
    PubMed     Related articles    Abstract available
    
    
    June 2007
38. BAO W , Behm DJ, Nerurkar SS, Ao Z, et al
    Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production.
    J Cardiovasc Pharmacol. 2007;49:362-368.
    PubMed     Related articles    Abstract available
    
    
    
39. CHAN YC , Leung FP, Yao X, Lau CW, et al
    Raloxifene Modulates Pulmonary Vascular Reactivity in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;49:355-361.
    PubMed     Related articles    Abstract available
    
    
    
40. PANDEY NR , Benkirane K, Amiri F, Schiffrin EL, et al
    Effects of PPAR-gamma Knock-down and Hyperglycemia on Insulin Signaling in Vascular Smooth Muscle Cells From Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;49:346-54.
    PubMed     Related articles    Abstract available
    
    
    
41. EGUCHI K , Tomizawa H, Ishikawa J, Hoshide S, et al
    Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    J Cardiovasc Pharmacol. 2007;49:394-400.
    PubMed     Related articles    Abstract available
    
    
    May 2007
42. NISHIOKA T , Suzuki M, Onishi K, Takakura N, et al
    Eplerenone Attenuates Myocardial Fibrosis in the Angiotensin II-Induced Hypertensive Mouse: Involvement of Tenascin-C Induced by Aldosterone-Mediated Inflammation.
    J Cardiovasc Pharmacol. 2007;49:261-268.
    PubMed     Related articles    Abstract available
    
    
    March 2007
43. EL-MAS MM , Abdel-Rahman AA
    Intermittent clonidine regimen abolishes tolerance to its antihypertensive effect: a spectral study.
    J Cardiovasc Pharmacol. 2007;49:174-81.
    PubMed     Related articles    Abstract available
    
    
    
44. ICHIHARA A , Kaneshiro Y, Sakoda M, Takemitsu T, et al
    Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker.
    J Cardiovasc Pharmacol. 2007;49:161-6.
    PubMed     Related articles    Abstract available
    
    
    February 2007
45. JACKSON EK , Gillespie DG, Jackson TC
    Phospholipase C and Src Modulate Angiotensin II-Induced Cyclic AMP Production in Preglomerular Microvascular Smooth-Muscle Cells From Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;49:106-110.
    PubMed     Related articles    Abstract available
    
    
    
46. DE BERRAZUETA JR , Gonzalez JP, de Mier I, Poveda JJ, et al
    Vasodilatory action of loop diuretics: a plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls.
    J Cardiovasc Pharmacol. 2007;49:90-5.
    PubMed     Related articles    Abstract available
    
    
    
47. JIANG BH , Tawara S, Abe K, Takaki A, et al
    Acute Vasodilator Effect of Fasudil, a Rho-kinase Inhibitor, in Monocrotaline-Induced Pulmonary Hypertension in Rats.
    J Cardiovasc Pharmacol. 2007;49:85-89.
    PubMed     Related articles    Abstract available
    
    
    
48. WESSEL N , Malberg H, Heringer-Walther S, Schultheiss HP, et al
    The Angiotensin-(1-7) Receptor Agonist AVE0991 Dominates the Circadian Rhythm and Baroreflex in Spontaneously Hypertensive Rats.
    J Cardiovasc Pharmacol. 2007;49:67-73.
    PubMed     Related articles    Abstract available
    
    
    January 2007
49. MA ZY , Li L, Zhong XZ, Tan HW, et al
    Cilnidipine improves left-ventricular midwall function independently of blood pressure changes in chinese patients with hypertension.
    J Cardiovasc Pharmacol. 2007;49:33-8.
    PubMed     Related articles    Abstract available
    
    
    
50. SITBON O , Manes A, Jais X, Pallazini M, et al
    Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension.
    J Cardiovasc Pharmacol. 2007;49:1-5.
    PubMed     Related articles    Abstract available
    
    
    December 2006
51. ABE K , Tawara S, Oi K, Hizume T, et al
    Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in Mice.
    J Cardiovasc Pharmacol. 2006;48:280-285.
    PubMed     Related articles    Abstract available
    
    
    November 2006
52. VAN ALBADA ME , van Veghel R, Cromme-Dijkhuis AH, Schoemaker RG, et al
    Treprostinil in Advanced Experimental Pulmonary Hypertension: Beneficial Outcome Without Reversed Pulmonary Vascular Remodeling.
    J Cardiovasc Pharmacol. 2006;48:249-254.
    PubMed     Related articles    Abstract available
    
    
    
53. GRANDI AM , Laurita E, Solbiati F, Marchesi C, et al
    Angiotensin-converting Enzyme Inhibitors Influence Left Ventricular Mass and Function Independently of the Antihypertensive Effect.
    J Cardiovasc Pharmacol. 2006;48:207-211.
    PubMed     Related articles    Abstract available
    
    
    September 2006
54. SONG J , Martin DS
    Rho kinase contributes to androgen amplification of renal vasoconstrictor responses in the spontaneously hypertensive rat.
    J Cardiovasc Pharmacol. 2006;48:103-9.
    PubMed     Related articles    Abstract available
    
    
    January 2006
55. K HOLLENBERG N
    Vascular action of cocoa flavanols in humans: the roots of the story.
    J Cardiovasc Pharmacol. 2006;47 Suppl 2:S99-102.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: